Literature DB >> 2263156

Trans-scleral application of a semiconductor diode laser.

G A Peyman1, K S Naguib, D Gaasterland.   

Abstract

We used a diode laser with an output power of 1 W through a fiberoptic light pipe (200 microns diameter) to deliver laser energy through the sclera of pigmented rabbits. Ciliary body destruction occurred with energy levels of 300-400 mW and exposure time of 0.5 sec. Retinal photocoagulation was achieved with energy levels of 200-500 mW in 0.5 sec. Histologic examination of acute lesions demonstrated thermal destruction of ciliary body processes and retina. Chorioretinal scar formation was observed clinically and histologically within 2-3 weeks. Our data indicate that the transscleral diode laser may be used for destruction of the ciliary body processes or peripheral retinal coagulation in pigmented eyes.

Entities:  

Mesh:

Year:  1990        PMID: 2263156     DOI: 10.1002/lsm.1900100609

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  10 in total

1.  Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system.

Authors:  S Ataullah; S Biswas; P H Artes; E O'Donoghue; A E A Ridgway; A F Spencer
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Transscleral Diode Laser Cyclophotocoagulation: A Comparison of Slow Coagulation and Standard Coagulation Techniques.

Authors:  Eric Rh Duerr; Mohamed S Sayed; Stephen Moster; Timothy Holley; Jin Peiyao; Elizabeth A Vanner; Richard K Lee
Journal:  Ophthalmol Glaucoma       Date:  2018-08-25

3.  The UK National Cyclodiode Laser Survey.

Authors:  P Agrawal; S Dulku; W Nolan; V Sung
Journal:  Eye (Lond)       Date:  2010-12-03       Impact factor: 3.775

4.  Transscleral and indirect ophthalmoscope diode laser retinal photocoagulation: experimental quantification of the therapeutic range for their application in the treatment of retinopathy of prematurity.

Authors:  A Obana; B Lorenz; R Birngruber
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-07       Impact factor: 3.117

Review 5.  Management of glaucoma: focus on pharmacological therapy.

Authors:  Robert E Marquis; Jess T Whitson
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Effect of contact diode laser on the cornea with and without absorbing dye.

Authors:  M A Karaçorlu; G A Peyman; S S Cruz
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

7.  Controlled Cyclophotocoagulation with diode laser in refractory glaucoma and long term follow up at King Abdulaziz University Hospital, Riyadh.

Authors:  Essam A Osman; Abdulrahman Al-Muammar; Ahmed Mousa; Hani Al-Mezaine; Saleh A Al-Obeidan
Journal:  Saudi J Ophthalmol       Date:  2010-01-07

8.  Trans-scleral diode laser cyclophotocoagulation for refractory glaucoma after high-risk penetrating keratoplasty.

Authors:  Alejandro Rodríguez-García; Luis Alonso González-González; J Carlos Alvarez-Guzmán
Journal:  Int Ophthalmol       Date:  2015-09-29       Impact factor: 2.031

9.  Recent advances in pharmacotherapy of glaucoma.

Authors:  S K Gupta; Galpalli Niranjan D; S S Agrawal; Sushma Srivastava; Rohit Saxena
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

10.  A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma.

Authors:  Philip A Bloom; Colin I Clement; Anthony King; Baha Noureddin; Kamal Sharma; Roger A Hitchings; Peng T Khaw
Journal:  Biomed Res Int       Date:  2013-10-07       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.